MX2011007693A - Metodos para amplificar acidos nucleicos del virus de hepatitis c. - Google Patents

Metodos para amplificar acidos nucleicos del virus de hepatitis c.

Info

Publication number
MX2011007693A
MX2011007693A MX2011007693A MX2011007693A MX2011007693A MX 2011007693 A MX2011007693 A MX 2011007693A MX 2011007693 A MX2011007693 A MX 2011007693A MX 2011007693 A MX2011007693 A MX 2011007693A MX 2011007693 A MX2011007693 A MX 2011007693A
Authority
MX
Mexico
Prior art keywords
seq
nucleotide sequence
nucleotides
set forth
optionally
Prior art date
Application number
MX2011007693A
Other languages
English (en)
Inventor
Chao Lin
Yi Zhou
Ann D Kwong
James Daniel Frantz
Douglas J Bartels
Benjamin Shames
Sheila Seepersaud
Judith A Lippke
Tara L Kieffer
Eileen Z Zhang
James C Sullivan
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of MX2011007693A publication Critical patent/MX2011007693A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00—Reactions of nucleic acids characterised by
    • C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113—PCR

Abstract

Un método de amplificación de un ácido nucleico de HCV en una muestra infectada con HCV comprende amplificar un segmento de plantilla de ADN complementario a un genoma de hacv de ARN de la muestra por una PCR de dos etapas, en donde un PCR de primera etapa emplea un primer cavador externo y un segundo cebador externo, y un PCR de segunda etapa emplea un primer cebador interno y un segundo cebador interno. La secuencia de nucleótidos del primer cebador externo comprende una secuencia de nucleótidos como se establece en SEQ ID NO: 2; o SEQ ID NO: 9, donde opcionalmente 1, 2 o 3 nucleótidos son nucleótidos diferentes a aquellos de SEQ ID NO: 9. La secuencia de nucleótidos del segundo cebador externo comprende una secuencia de nucleótidos como se establece en SEQ ID NO: 3 o 4; o una secuencia de nucleótidos establecida en SEQ ID NO: 10 o 11, donde opcionalmente 1, 2 o 3 nucleótidos son nucleótidos diferentes a aquellos d SEQ ID NO: 10 y 11. La secuencia de nucleótidos del primer cebador interno comprende una secuencia de nucleótidos como se establece en SEQ ID NO: 5; o SEQ ID NO: 12, donde opcionalmente 1, 2 o 3 nucleótidos son nucleótidos diferentes a aquellos de SEQ ID NO: 12.
MX2011007693A 2009-01-21 2010-01-21 Metodos para amplificar acidos nucleicos del virus de hepatitis c. MX2011007693A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14608309P 2009-01-21 2009-01-21
PCT/US2010/021589 WO2010090857A2 (en) 2009-01-21 2010-01-21 Methods for amplifying hepatitis c virus nucleic acids

Publications (1)

Publication Number Publication Date
MX2011007693A true MX2011007693A (es) 2011-09-27

Family

ID=42334055

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011007693A MX2011007693A (es) 2009-01-21 2010-01-21 Metodos para amplificar acidos nucleicos del virus de hepatitis c.

Country Status (13)

Country Link
US (2) US8679740B2 (es)
EP (1) EP2389452A2 (es)
JP (1) JP2012515534A (es)
KR (1) KR20120101278A (es)
CN (1) CN102341506A (es)
AU (1) AU2010210892A1 (es)
CA (1) CA2749969A1 (es)
IL (1) IL214195A0 (es)
MX (1) MX2011007693A (es)
NZ (1) NZ594155A (es)
RU (1) RU2011134857A (es)
WO (1) WO2010090857A2 (es)
ZA (1) ZA201105349B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2934220C (en) 2007-10-02 2019-11-05 Theranos, Inc. Modular point-of-care devices and uses thereof
AR085087A1 (es) 2011-01-21 2013-09-11 Theranos Inc Sistemas y metodos para maximizar el uso de muestras
US8840838B2 (en) 2011-09-25 2014-09-23 Theranos, Inc. Centrifuge configurations
US9632102B2 (en) 2011-09-25 2017-04-25 Theranos, Inc. Systems and methods for multi-purpose analysis
US20140170735A1 (en) 2011-09-25 2014-06-19 Elizabeth A. Holmes Systems and methods for multi-analysis
US9268915B2 (en) 2011-09-25 2016-02-23 Theranos, Inc. Systems and methods for diagnosis or treatment
US8475739B2 (en) 2011-09-25 2013-07-02 Theranos, Inc. Systems and methods for fluid handling
US9664702B2 (en) 2011-09-25 2017-05-30 Theranos, Inc. Fluid handling apparatus and configurations
US9619627B2 (en) 2011-09-25 2017-04-11 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US10012664B2 (en) 2011-09-25 2018-07-03 Theranos Ip Company, Llc Systems and methods for fluid and component handling
US9250229B2 (en) 2011-09-25 2016-02-02 Theranos, Inc. Systems and methods for multi-analysis
US9810704B2 (en) 2013-02-18 2017-11-07 Theranos, Inc. Systems and methods for multi-analysis
CN105683751B (zh) 2013-09-06 2020-01-17 赛拉诺斯知识产权有限责任公司 用于接收拭子的装置、***、方法和套件
EP3042208A4 (en) 2013-09-06 2017-04-19 Theranos, Inc. Systems and methods for detecting infectious diseases
CN106222306A (zh) * 2016-08-30 2016-12-14 合肥金域医学检验所有限公司 一种hcv病毒ns5a蛋白编码序列突变检测试剂盒

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4415732A (en) 1981-03-27 1983-11-15 University Patents, Inc. Phosphoramidite compounds and processes
US4973679A (en) 1981-03-27 1990-11-27 University Patents, Inc. Process for oligonucleo tide synthesis using phosphormidite intermediates
DE3329892A1 (de) 1983-08-18 1985-03-07 Köster, Hubert, Prof. Dr., 2000 Hamburg Verfahren zur herstellung von oligonucleotiden
FR2596761B1 (fr) 1986-04-08 1988-05-20 Commissariat Energie Atomique Derives de nucleosides et leur utilisation pour la synthese d'oligonucleotides
US5310652A (en) 1986-08-22 1994-05-10 Hoffman-La Roche Inc. Reverse transcription with thermostable DNA polymerase-high temperature reverse transcription
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
DE69233083T2 (de) 1991-08-27 2003-12-18 Hoffmann La Roche Primers und Sondern zum Nachweis von Hepatitis C
US5427909A (en) * 1991-09-09 1995-06-27 Immuno Japan Inc. Oligonucleotides and determination system of HCV genotypes
JPH0775585A (ja) * 1993-06-14 1995-03-20 Immuno Japan:Kk Ｃ型肝炎ウイルス関連オリゴヌクレオチドならびにｃ型肝炎 ウイルス遺伝子型判定方法
ZA966663B (en) 1995-08-17 1998-02-06 Genentech Inc Traf Inhibitors.
US6153421A (en) * 1997-07-18 2000-11-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Cloned genomes of infectious hepatitis C viruses and uses thereof
US6790952B2 (en) * 2001-02-13 2004-09-14 Cincinnati Children's Hospital Research Foundation Quantitative epstein barr virus PCR rapid assay
JP3751867B2 (ja) * 2001-09-18 2006-03-01 株式会社東芝 インターフェロンを投与されるべき個体においてインターフェロン療法の有効性を予測する方法、その方法をコンピュータにより実行させるためのプログラム、インターフェロン感受性に関連する多型部位の遺伝子型を検出するための核酸プローブ、およびその核酸プローブを具備する塩基配列検出用チップ
US20050250093A1 (en) * 2002-04-03 2005-11-10 Gates Adam T Hepatitis c virus sub-genomic replicons
US20040137539A1 (en) * 2003-01-10 2004-07-15 Bradford Sherry A. Cancer comprehensive method for identifying cancer protein patterns and determination of cancer treatment strategies
JP2006517960A (ja) 2003-02-18 2006-08-03 ファイザー インコーポレイテッド Ｃ型肝炎ウイルスの阻害剤、それを使用する組成物および治療法
US20050282179A1 (en) 2003-12-05 2005-12-22 Applera Corporation Biomarkers for interferon-alpha response in hepatitis C virus infected patients
WO2006085407A1 (ja) * 2005-02-09 2006-08-17 Nihon University Hcv量に関連する遺伝子のスクリーニング方法
AU2008246622B2 (en) * 2007-04-27 2013-09-26 Advanced Life Science Institute, Inc. HCV gene
JP4213759B2 (ja) * 2007-08-10 2009-01-21 株式会社東芝 標的核酸の遺伝子型、および変異の判定方法、不溶性支持体に核酸断片を固定化する方法、所望の核酸を精製し、かつ増幅するための方法、並びに遺伝子型アッセイキット

Also Published As

Publication number Publication date
US20120129155A1 (en) 2012-05-24
US20140199684A1 (en) 2014-07-17
NZ594155A (en) 2013-02-22
CN102341506A (zh) 2012-02-01
EP2389452A2 (en) 2011-11-30
JP2012515534A (ja) 2012-07-12
RU2011134857A (ru) 2013-02-27
WO2010090857A3 (en) 2010-11-25
ZA201105349B (en) 2013-10-30
IL214195A0 (en) 2011-08-31
AU2010210892A1 (en) 2011-08-11
US8679740B2 (en) 2014-03-25
KR20120101278A (ko) 2012-09-13
WO2010090857A8 (en) 2012-06-28
CA2749969A1 (en) 2010-08-12
WO2010090857A2 (en) 2010-08-12

Similar Documents

Publication Publication Date Title
MX2011007693A (es) Metodos para amplificar acidos nucleicos del virus de hepatitis c.
Li et al. Improved rapid amplification of cDNA ends (RACE) for mapping both the 5′ and 3′ terminal sequences of paramyxovirus genomes
MX346956B (es) Captura directa, amplificación y secuenciación de objetivo adn usando cebadores inmovilizados.
EP2580355A4 (en) A REVERSE TRANSCRIPTION AND THROUGH BASE-SPACING RESTRICTED QUANTITATIVE PCR PROVIDED THROUGH AN OLIGONUCLEOTIDE WITH A CHANGED HAIR NEEDLE STRUCTURE
EA201791991A1 (ru) Способ улучшения способности противодействовать внедренным днк-содержащим вирусам растения
WO2005014806A3 (en) Conserved hbv and hcv sequences useful for gene silencing
WO2009102896A3 (en) Isothermal nucleic acid amplification methods and compositions
WO2006074162A3 (en) Primer generation rolling circle amplification
RU2012105647A (ru) Способ удаления загрязняющей нуклеиновой кислоты из реакций обратной транскрипции и амплификации
WO2006026388A3 (en) Single-primer nucleic acid amplification methods
WO2006069064A3 (en) Conserved hbv and hcv sequences useful for gene silencing
JP2011502502A5 (es)
EP3358014A3 (en) Method for stabilizing functional nucleic acids
WO2009073629A3 (en) Efficient shotgun sequencing methods
WO2012092569A3 (en) Compositions comprising immunostimulatory nucleic acids and related methods
AU2009355009A8 (en) THD primer target detection
WO2012046981A3 (en) Real time pcr detection of single nucleotide polymorphisms
EP2090653A4 (en) PROCESS FOR DETECTION OF APPLE MOSAIC VIRUS, PRIMER'S TEST FOR PROOF AND KIT FOR PROOF
CN115335536A (zh) 用于即时核酸检测的组合物和方法
WO2010080782A3 (en) Random homozygous gene perburbation (rhgp) with thermal assymetric interlaced (tail)-pcr
JP2014003946A5 (es)
JP2014521312A5 (es)
JP2013539969A (ja) カリシウイルスのｒｎａポリメラーゼによる、マイクロ波によって駆動されるｒｎａ重合
NZ611657A (en) Compositions and methods for identifying and differentiating viral components of multivalent shipping fever vaccines
KR101510666B1 (ko) 병원체 유전자를 사용하지 않는 피시알용 양성대조구 플라스미드

Legal Events

Date Code Title Description
FA Abandonment or withdrawal